Skip to content
OpenCapital
Get started

Arcus Biosciences RCUS License and development services — Total revenues

Other product segments

R&D services
$2M0.0%

Similar metrics at other companies

Vir Biotechnology, Inc. logo
VIRLicense and collaboration revenue — Total revenues
-$41K+41.4%
Tarsus Pharmaceuticals, Inc. logo
TARSLicense fees and collaboration revenue — Total revenues
$16.67M—
BioCryst Pharmaceuticals logo
BCRXLicense and other revenues — Total revenues
$5.01M+187%
Rhythm Pharmaceuticals, Inc. logo
RYTMLicense revenue — Total revenues
$0+100%
Travere Therapeutics, Inc. logo
TVTXLicense and collaboration revenue — Total Revenue
$2.71M-54.1%
Crinetics Pharmaceuticals logo
CRNXCollaboration and license revenue — Total Revenue
$428K+18.6%

Other financials

Income statement

See full
Revenue$17.0M-39.3%
Operating income-$134.0M-9.8%
Net income-$128.0M-14.3%
EPS (diluted)-$1.02+10.5%

Balance sheet

See full
Cash & equivalents$201.0M+4.7%
Total debt$113.0M+88.3%
Total equity$524.0M-1.3%
Total assets$997.0M-13.8%

Cash flow

See full
Operating cash flow-$138.0M-4.5%
CapEx--100%
Free cash flow-$138.0M-3.8%

Valuation

See full
Market cap$3.54B+226%
Enterprise value$3.46B+275%
P/S15×+7.3×

Profitability

See full
Operating margin-168.6%-52.7pp
Net margin-156.4%-47.5pp
FCF margin-207.2%—

Returns & leverage

See full
Return on equity-70%+8.4pp
Debt / equity0.2×+0.1×
Current ratio4×-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's license and development services — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcus Biosciences's license and development services — total revenues?
Arcus Biosciences (RCUS) reported license and development services — total revenues of $12M in Q1 2026.
How has Arcus Biosciences's license and development services — total revenues changed year-over-year?
Arcus Biosciences's license and development services — total revenues decreased by 40.0% year-over-year, from $20M to $12M.
What does license and development services — total revenues mean?
This metric represents the total revenue recognized from licensing intellectual property and providing research and development services to strategic partners. It reflects the company's ability to monetize its clinical-stage pipeline through collaborative agreements and milestone-based payments. This revenue stream is a critical indicator of the commercial validation of the company's proprietary drug candidates.